Pharmaceutical Product
-
{
- All
- News
- Videos
-
Fake Mounjaro In India: Eli Lilly Issues Tips And Checklist To Identify Fakes
In a significant move to protect consumers, the Haryana State-FDA recently conducted a successful operation in Gurugram, seizing counterfeit products falsely labelled as Mounjaro (tirzepatide).
-
'Two ways of calculating': Trump Defends His Calculations On Drug Prices
Trump defended his claims that prices on prescription medications had been cut by well over 100per cent - something that is mathematically impossible.
-
Health Ministry Mulls Ban On Cough Syrups For Children Under 2 Years: Report
New Delhi, April 11 (IANS) Health Ministry is reportedly considering banning prescriptions of paediatric cough syrups for children under two years and discouraging their use for those under five.
-
India's Pharma Opportunity: Expanding Global Reach In A Changing Healthcare Landscape
India's pharmaceutical industry is now at a critical juncture in its evolution.
-
Trump Imposes 100% Tariffs On Patented Drugs: Will It Impact India?
The bigger picture threatens a move away from established production hubs like India.
-
US Company Recalls Chocolate Products Containing Hidden Erectile Dysfunction Drugs
A California-based company recalled chocolate products that contained "undeclared" pharmaceutical ingredients, sildenafil and tadalafil.
-
What Are Semaglutide Generics? Here's Why They Matter More In India Now
Semaglutide works by imitating the natural hormone glucagon-like peptide-1 (GLP-1), which plays a key role in managing blood sugar.
-
Pakistan Faces Critical Medicine Shortage Amid Import Disruptions, Only 45 Days Of Supply Remain
Pakistan faces critical medicine shortages as Middle East conflict disrupts imports of pharmaceutical raw materials and essential supplies.
-
India-US Trade Deal Likely To Offer Tariff Relief On Exported Medicines
India's pharmaceutical industry has welcomed the interim trade agreement framework between India and the US, which offers tariff relief on medicines and several other Indian exports.
-
India-EU Trade Deal Opens Up Both Regions As Major Affordable Medicine Suppliers: Indian Pharmaceutical Alliance
Speaking on the significance of the agreement, Sudarshan Jain, General Secretary, Indian Pharmaceutical Alliance, said that the India-EU FTA is a landmark development, particularly for the pharmaceutical sector.
-
Indian Drugmakers Recall Medicines In The US Over Manufacturing Issues
Indian drugmakers Sun Pharmaceutical Industries and Cipla have recalled certain products from the US market due to manufacturing-related issues, according to the latest update from the US Food and Drug Administration (USFDA).
-
Chandrababu Naidu Showcases Andhra As Hub For Global Investments At Davos
Andhra Pradesh has initiated at least 25 new policies for industrial development and is encouraging investments in digital media and virtual production, Chief Minister N Chandrababu Naidu has said in multiple interactions in Davos.
-
364 Violations Found At Pharma Company Behind 'Killer' Cough Syrup: Sources
The pharmaceutical company, Sresan Pharma, at the centre of the cough syrup tragedy that has claimed over a dozen children's lives in Madhya Pradesh was found to be supplying the cough syrup without testing it, said a top source.
-
Countries And Companies Threatened By Trump's 100% Tariffs On Pharma
Donald Trump has shocked the global drug industry by announcing 100-percent tariffs on all branded, imported pharmaceutical products -- unless companies are building manufacturing plants in the United States.
-
Trump's 100% Tariff On Pharma Will Not Impact Generic Makers: Industry Leaders
Indian Pharmaceutical Alliance (IPA) on Friday said US President Donald Trump's move to impose 100 per cent import tariffs on pharmaceutical drugs from October 1 will impact only patented and branded products, not generic medicines.
-
Fake Mounjaro In India: Eli Lilly Issues Tips And Checklist To Identify Fakes
In a significant move to protect consumers, the Haryana State-FDA recently conducted a successful operation in Gurugram, seizing counterfeit products falsely labelled as Mounjaro (tirzepatide).
-
'Two ways of calculating': Trump Defends His Calculations On Drug Prices
Trump defended his claims that prices on prescription medications had been cut by well over 100per cent - something that is mathematically impossible.
-
Health Ministry Mulls Ban On Cough Syrups For Children Under 2 Years: Report
New Delhi, April 11 (IANS) Health Ministry is reportedly considering banning prescriptions of paediatric cough syrups for children under two years and discouraging their use for those under five.
-
India's Pharma Opportunity: Expanding Global Reach In A Changing Healthcare Landscape
India's pharmaceutical industry is now at a critical juncture in its evolution.
-
Trump Imposes 100% Tariffs On Patented Drugs: Will It Impact India?
The bigger picture threatens a move away from established production hubs like India.
-
US Company Recalls Chocolate Products Containing Hidden Erectile Dysfunction Drugs
A California-based company recalled chocolate products that contained "undeclared" pharmaceutical ingredients, sildenafil and tadalafil.
-
What Are Semaglutide Generics? Here's Why They Matter More In India Now
Semaglutide works by imitating the natural hormone glucagon-like peptide-1 (GLP-1), which plays a key role in managing blood sugar.
-
Pakistan Faces Critical Medicine Shortage Amid Import Disruptions, Only 45 Days Of Supply Remain
Pakistan faces critical medicine shortages as Middle East conflict disrupts imports of pharmaceutical raw materials and essential supplies.
-
India-US Trade Deal Likely To Offer Tariff Relief On Exported Medicines
India's pharmaceutical industry has welcomed the interim trade agreement framework between India and the US, which offers tariff relief on medicines and several other Indian exports.
-
India-EU Trade Deal Opens Up Both Regions As Major Affordable Medicine Suppliers: Indian Pharmaceutical Alliance
Speaking on the significance of the agreement, Sudarshan Jain, General Secretary, Indian Pharmaceutical Alliance, said that the India-EU FTA is a landmark development, particularly for the pharmaceutical sector.
-
Indian Drugmakers Recall Medicines In The US Over Manufacturing Issues
Indian drugmakers Sun Pharmaceutical Industries and Cipla have recalled certain products from the US market due to manufacturing-related issues, according to the latest update from the US Food and Drug Administration (USFDA).
-
Chandrababu Naidu Showcases Andhra As Hub For Global Investments At Davos
Andhra Pradesh has initiated at least 25 new policies for industrial development and is encouraging investments in digital media and virtual production, Chief Minister N Chandrababu Naidu has said in multiple interactions in Davos.
-
364 Violations Found At Pharma Company Behind 'Killer' Cough Syrup: Sources
The pharmaceutical company, Sresan Pharma, at the centre of the cough syrup tragedy that has claimed over a dozen children's lives in Madhya Pradesh was found to be supplying the cough syrup without testing it, said a top source.
-
Countries And Companies Threatened By Trump's 100% Tariffs On Pharma
Donald Trump has shocked the global drug industry by announcing 100-percent tariffs on all branded, imported pharmaceutical products -- unless companies are building manufacturing plants in the United States.
-
Trump's 100% Tariff On Pharma Will Not Impact Generic Makers: Industry Leaders
Indian Pharmaceutical Alliance (IPA) on Friday said US President Donald Trump's move to impose 100 per cent import tariffs on pharmaceutical drugs from October 1 will impact only patented and branded products, not generic medicines.
